Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver

Food and Chemical Toxicology

Volumn 46, Issue 4, 2008, Pages 1230-1238

  Huber, Wolfgang W ^a   Rossmanith, Walter ^a   Grusch, Michael ^a   Haslinger, Elisabeth ^a   Prustomersky, Sonja ^a   Peter Vörösmarty, Barbara ^a   Parzefall, Wolfram ^a   Scharf, Gerlinde ^a   Schulte Hermann, Rolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cafestol; Coffee components; Cytochrome P450; Kahweol; Liver; Rat; Sulfotransferase

Indexed keywords

CAFESTOL; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; ETHOXYRESORUFIN DEETHYLASE; KAHWEOL; MESSENGER RNA; RESORUFIN; SULFOTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENICITY; CHEMOPROPHYLAXIS; COFFEE; COLON CANCER; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME ASSAY; FOOD COMPOSITION; GENE EXPRESSION; LIVER CANCER; LIVER METABOLISM; MALE; MUTAGENICITY; NONHUMAN; RAT; XENOBIOTIC METABOLISM;

ANIMALS; ANTICARCINOGENIC AGENTS; ARYLSULFOTRANSFERASE; COFFEE; CYTOCHROME P-450 ENZYME SYSTEM; DITERPENES; FILTRATION; ISOENZYMES; LIVER; MALE; NUCLEASE PROTECTION ASSAYS; RATS; RATS, INBRED F344; RNA;

ANIMALIA; RATTUS;

EID: 39149134628     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.09.094     Document Type: Article

References (63)

1. Adamson R.H., Thorgeirsson U.P., and Sugimura T. Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans. Arch. Toxicol. Suppl. 18 (1996) 303-318
2. Akagawa M., Shigemitsu T., and Suyama K. Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions. Biosci. Biotechnol. Biochem. 67 (2003) 2632-2640
3. Ayalogu E.O., Snelling J., Lewis D.F., Talwar S., Clifford M.N., and Ioannides C. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim. Biophys. Acta 1272 (1995) 89-94
4. Barker C.W., Fagan J.B., and Pasco D.S. Down-regulation of P4501A1 and P4501A2 mRNA expression in isolated hepatocytes by oxidative stress. J. Biol. Chem. 269 (1994) 3985-3990
5. Berthou F., Goasduff T., Dreano Y., and Menez J.F. Caffeine increases its own metabolism through cytochrome P4501A induction in rats. Life Sci. 57 (1995) 541-549
6. Bradford M.A. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein binding. Anal. Biochem. 72 (1976) 248-254
7. Buonarati M.H., Turteltaub K.W., Shen N.H., and Felton J.S. Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutat. Res. 245 (1990) 185-190
8. Burke M.D., and Mayer R.T. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2 (1974) 583-588
9. Cavin C., Holzhauser D., Constable A., Huggett A.C., and Schilter B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 19 (1998) 1369-1375
10. Cavin C., Mace K., Offord E.A., and Schilter B. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem. Toxicol. 39 (2001) 549-556
11. Cavin C., Bezencon C., Guignard G., and Schilter B. Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems. Biochem. Biophys. Res. Commun. 306 (2003) 488-495
12. Coles B., Nowell S.A., MacLeod S.L., Sweeney C., Lang N.P., and Kadlubar F.F. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat. Res. 482 (2001) 3-10
13. Debersac P., Vernevaut M.F., Amiot M.J., Suschetet M., and Siess M.H. Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver. Food Chem. Toxicol. 39 (2001) 109-117
14. Flammang T.J., Yamazoe Y., Benson R.W., Roberts D.W., Potter D.W., Chu D.Z., Lang N.P., and Kadlubar F.F. Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res. 49 (1989) 1977-1982
15. Frame L.T., Ozawa S., Nowell S.A., Chou H.C., DeLongchamp R.R., Doerge D.R., Lang N.P., and Kadlubar F.F. A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. Drug Metab. Dispos. 28 (2000) 1063-1068
16. Gallus S., Bertuzzi M., Tavani A., Bosetti C., Negri E., La Vecchia C., Lagiou P., and Trichopoulos D. Does coffee protect against hepatocellular carcinoma?. Br. J. Cancer. 87 (2002) 956-959
17. Gallus S., Tavani A., Negri E., and La Vecchia C. Does coffee protect against liver cirrhosis?. Ann. Epidemiol. 12 (2002) 202-205
18. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am. J. Epidemiol. 147 (1998) 1043-1052
19. Goasduff T., Dreano Y., Guillois B., Menez J.F., and Berthou F. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol. 52 (1996) 1915-1919
20. Gross G., Jaccaud E., and Huggett A.C. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem. Toxicol. 35 (1997) 547-554
21. Huber W.W., McDaniel L.P., Kaderlik K.R., Teitel C.H., Lang N.P., and Kadlubar F.F. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 376 (1997) 115-122
22. Huber W.W., Prustomersky S., Delbanco E., Uhl M., Scharf G., Turesky R.J., Thier R., and Schulte Hermann R. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch. Toxicol. 76 (2002) 209-217
23. Huber W.W., Scharf G., Rossmanith W., Prustomersky S., Grasl Kraupp B., Peter B., Turesky R.J., and Schulte Hermann R. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch. Toxicol. 75 (2002) 685-694
24. 6-methylguanine-DNA methyltransferase in rat liver--comparison with phase II xenobiotic metabolism. Mutat. Res.-Fund. Mol. Mech. Mutagen. 522 (2003) 57-68
25. Huber W.W., Teitel C.H., Coles B.F., King R.S., Wiese F.W., Kaderlik K.R., Casciano D.A., Shaddock J.G., Mulder G.J., Ilett K.F., and Kadlubar F.F. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ. Mol. Mutagen. 44 (2004) 265-276
26. Huber W.W., and Parzefall W. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods Enzymol. 401 (2005) 307-341
27. IARC (1991) Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. WHO, Lyon, France.
28. Kawajiri, K., Gotoh, O., Sogawa, K., Tagashira, Y., Muramatsu, M., Fujii-Kuriyama, Y., 1984. Coding nucleotide sequence of 3-methylcholanthrene-inducible cytochrome P-450d cDNA from rat liver. Proceedings of the National Academy of Sciences of the United States of America 81, pp. 1649-1653.
29. Kitts D.D., and Wijewickreme A.N. Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems. Plant Foods Hum. Nutr. 45 (1994) 287-298
30. Krajka-Kuzniak V., and Baer-Dubowska W. The effects of tannic acid on cytochrome P450 and phase II enzymes in mouse liver and kidney. Toxicol. Lett. 143 (2003) 209-216
31. Lam L.K., Sparnins V.L., and Wattenberg L.W. Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice. J. Med. Chem. 30 (1987) 1399-1403
32. Landi M.T., Sinha R., Lang N.P., and Kadlubar F.F. Human cytochrome P4501A2 (1999), Springer pp.173-195
33. Le Marchand L., Franke A.A., Custer L., Wilkens L.R., and Cooney R.V. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7 (1997) 11-19
34. Majer B.J., Hofer E., Cavin C., Lhoste E., Uhl M., Glatt H.R., Meinl W., and Knasmuller S. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem. Toxicol. 43 (2005) 433-441
35. Manson M.M., Ball H.W., Barrett M.C., Clark H.L., Judah D.J., Williamson G., and Neal G.E. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis 18 (1997) 1729-1738
36. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., and Hayes J.D. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61 (2001) 3299-3307
37. Miller E.G., McWhorter K., Rivera-Hidalgo F., Wright J.M., Hirsbrunner P., and Sunahara G.I. Kahweol and cafestol: inhibitors of hamster buccal pouch carcinogenesis. Nutr. Cancer 15 (1991) 41-46
38. Morel Y., and Barouki R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J. Biol. Chem. 273 (1998) 26969-26976
39. Mori Y., Koide A., Kobayashi Y., Morimura K., Kaneko M., and Fukushima S. Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver. Mutagenesis 17 (2002) 251-256
40. Nebert D.W., and Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 6 (2006) 947-960
41. Nowell S., Coles B., Sinha R., MacLeod S., Luke Ratnasinghe D., Stotts C., Kadlubar F.F., Ambrosone C.B., and Lang N.P. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat. Res. (2002) 175-185
42. Oesch-Bartlomowicz B., Richter B., Becker R., Vogel S., Padma P.R., Hengstler J.G., and Oesch F. cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control in vitro and in vivo. Int J. Cancer 94 (2001) 733-742
43. Post S.M., de Wit E.C., and Princen H.M. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3064-3070
44. Rossmanith W., Bettinger E., Cerni C., and Karwan R.M. Expression of mouse RNase MRP RNA in human embryonic kidney 293 cells. Mol. Biol. Rep. 24 (1997) 221-230
45. Rossmanith W., Chabicovsky M., Grasl-Kraupp B., Peter B., Schausberger E., and Schulte-Hermann R. Follistatin overexpression in rodent liver tumors: A possible mechanism to overcome activin growth control. Mol. Carcinog. 35 (2002) 1-5
46. Scharf G., Prustomersky S., Knasmuller S., Schulte-Hermann R., and Huber W.W. Enhancement of glutathione and gamma-glutamylcysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2. Nutr. Cancer 45 (2003) 74-83
47. Schilter B., Perrin I., Cavin C., and Huggett A.C. Placental glutathione S-transferase (GST-P) induction as a potential mechanism for the anti-carcinogenic effect of the coffee-specific components cafestol and kahweol. Carcinogenesis 17 (1996) 2377-2384
48. Shu L., and Hollenberg P.F. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1. Carcinogenesis 18 (1997) 801-810
49. Sohn O.S., Fiala E.S., Requeijo S.P., Weisburger J.H., and Gonzalez F.J. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res. 61 (2001) 8435-8440
50. Song B.J., Gelboin H.V., Park S.S., Yang C.S., and Gonzalez F.J. Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J. Biol. Chem. 261 (1986) 16689-16697
51. Suwa Y., Mizukami Y., Sogawa K., and Fujii-Kuriyama Y. Gene structure of a major form of phenobarbital-inducible cytochrome P-450 in rat liver. J. Biol. Chem. 260 (1985) 7980-7984
52. Szaefer H., Jodynis-Liebert J., Cichocki M., Matuszewska A., and Baer-Dubowska W. Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by O-toluidine. Toxicology 186 (2003) 67-77
53. Tantcheva-Poor I., Zaigler M., Rietbrock S., and Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9 (1999) 131-144
54. Tavani A., and La Vecchia C. Coffee and cancer: a review of epidemiological studies, 1990-1999. Eur. J. Cancer Prev. 9 (2000) 241-256
55. Tavani A., and La Vecchia C. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes Control 15 (2004) 743-757
56. Tso J.Y., Sun X.H., Kao T.H., Reece K.S., and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13 (1985) 2485-2502
57. Turesky R.J., Lang N.P., Butler M.A., Teitel C.H., and Kadlubar F.F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12 (1991) 1839-1845
58. Urgert R., van der Weg G., Kosmeijer-Schuil T.G., van de Bovenkamp P., Hovenier R., and Katan M.B. Levels of the cholesterol-elevating diterpenes Cafestol and Kahweol in various coffee brews. J. Agric. Food Chem. 43 (1995) 2167-2172
59. E: evidence for the formation of novel activin dimers. J. Mol. Endocrinol. 28 (2002) 137-148
60. Wang H., Kawashima H., and Strobel H.W. cDNA cloning of a novel CYP3A from rat brain. Biochemical and biophysical research communications 221 (1996) 157-162
61. Xu C., and Pasco D.S. Suppression of CYP1A1 transcription by H2O2 is mediated by xenobiotic-response element. Arch. Biochem. Biophys. 356 (1998) 142-150
62. Yabusaki Y., Shimizu M., Murakami H., Nakamura K., Oeda K., and Ohkawa H. Nucleotide sequence of a full-length cDNA coding for 3-methylcholanthrene-induced rat liver cytochrome P-450MC. Nucleic Acids Res. 12 (1984) 2929-2938
63. Zierold C., Mings J.A., and Deluca H.F. 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro. Mol. Pharmacol. 69 (2006) 1740-1747